Q32 Bio Inc. 8-K

What Happened

• Q32 Bio Inc. (QTTB) announced its financial results for the quarter ended December 31, 2025 and provided a corporate update in a press release. The company filed a Current Report on Form 8-K dated March 10, 2026 to furnish this information.

Key Details

• Filing date: March 10, 2026 (Form 8-K, Item 2.02 for results of operations and financial condition).
• Period covered: Quarter ended December 31, 2025.
• Press release furnished as Exhibit 99.1 to the Form 8-K.
• The Form 8-K was signed by CEO Jodie Morrison; the disclosure is furnished (not “filed”) and is not incorporated by reference into other securities filings except where expressly stated.

Why It Matters

• This filing notifies investors that Q32 Bio has provided its latest quarterly results and corporate update; the press release is the primary source for the detailed financial metrics and business developments. Investors should review Exhibit 99.1 (the press release) for revenue, expenses, cash position, guidance (if any), and management commentary to assess near-term performance and outlook.